Drug recall · February 11, 2026
Bisoprolol Fumarate and Hydrochlorothiazide tablets recall
Why: cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIS LTD., Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India, Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC., East Brunswick, NJ 08816, NDC 29300-187-01
- Lots / codes
Lot # GBHL24005A, Exp Date: 09/2026
- Quantity
- N/A
- Company
- Unichem Pharmaceuticals USA Inc., East Brunswick, NJ
- Distribution
- US Nationwide and PR.
- Initiated
- January 21, 2026 · Voluntary: Firm initiated
- Classified
- January 30, 2026
- Reported
- February 11, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bisoprolol / hydrochlorothiazide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.